JP2010523662A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010523662A5 JP2010523662A5 JP2010503031A JP2010503031A JP2010523662A5 JP 2010523662 A5 JP2010523662 A5 JP 2010523662A5 JP 2010503031 A JP2010503031 A JP 2010503031A JP 2010503031 A JP2010503031 A JP 2010503031A JP 2010523662 A5 JP2010523662 A5 JP 2010523662A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- desmethylvenlafaxine
- composition according
- administered
- sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- KYYIDSXMWOZKMP-UHFFFAOYSA-N O-desmethylvenlafaxine Chemical compound C1CCCCC1(O)C(CN(C)C)C1=CC=C(O)C=C1 KYYIDSXMWOZKMP-UHFFFAOYSA-N 0.000 claims 7
- ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 claims 4
- 239000013543 active substance Substances 0.000 claims 4
- 229960002866 duloxetine Drugs 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 claims 2
- 206010041349 Somnolence Diseases 0.000 claims 2
- 239000000883 anti-obesity agent Substances 0.000 claims 2
- 229940125710 antiobesity agent Drugs 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000003623 enhancer Substances 0.000 claims 2
- 230000029058 respiratory gaseous exchange Effects 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- KYYIDSXMWOZKMP-OAHLLOKOSA-N 4-[(1s)-2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol Chemical compound C1([C@@H](CN(C)C)C2(O)CCCCC2)=CC=C(O)C=C1 KYYIDSXMWOZKMP-OAHLLOKOSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 208000001797 obstructive sleep apnea Diseases 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92246607P | 2007-04-09 | 2007-04-09 | |
| PCT/US2008/004508 WO2008124128A2 (en) | 2007-04-09 | 2008-04-08 | Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010523662A JP2010523662A (ja) | 2010-07-15 |
| JP2010523662A5 true JP2010523662A5 (enExample) | 2011-05-19 |
Family
ID=39831524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010503031A Pending JP2010523662A (ja) | 2007-04-09 | 2008-04-08 | 睡眠関連呼吸障害を処置するための方法及び組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20080293823A1 (enExample) |
| EP (2) | EP2455076A1 (enExample) |
| JP (1) | JP2010523662A (enExample) |
| KR (1) | KR20100015923A (enExample) |
| CN (1) | CN101686955A (enExample) |
| AR (1) | AR065989A1 (enExample) |
| AU (1) | AU2008236624A1 (enExample) |
| BR (1) | BRPI0810159A2 (enExample) |
| CA (1) | CA2683697C (enExample) |
| IL (1) | IL201430A0 (enExample) |
| MX (1) | MX2009010805A (enExample) |
| NZ (1) | NZ580250A (enExample) |
| RU (1) | RU2009141168A (enExample) |
| TW (1) | TW200901956A (enExample) |
| WO (1) | WO2008124128A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011085256A2 (en) * | 2010-01-07 | 2011-07-14 | Vivus, Inc. | Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
| WO2011155797A2 (ko) * | 2010-06-10 | 2011-12-15 | 동아제약 주식회사 | 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물 |
| JP7422666B2 (ja) | 2018-01-30 | 2024-01-26 | アプニメッド，インコーポレイテッド（デラウェア） | 睡眠時無呼吸を治療するための方法および組成物 |
| SG11202108225QA (en) * | 2019-02-08 | 2021-08-30 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| US5803066A (en) * | 1992-05-07 | 1998-09-08 | New York University | Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US6150396A (en) * | 1997-03-07 | 2000-11-21 | Eli Lilly And Company | Methods of treating or preventing interstitial cystitis |
| JP2002501892A (ja) | 1998-01-29 | 2002-01-22 | セプラコア インコーポレーテッド | 光学的に純粋な（−）−ビュープロピオンの薬学的使用 |
| US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
| ES2305606T3 (es) * | 1999-04-06 | 2008-11-01 | Sepracor Inc. | Succinato de o-desmetilvenlafaxina. |
| WO2000076955A1 (en) * | 1999-06-15 | 2000-12-21 | American Home Products Corporation | Enantiomers of o-desmethyl venlafaxine |
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| WO2005079761A1 (en) * | 2004-02-17 | 2005-09-01 | Transoral Pharmaceuticals, Inc. | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| US20060039866A1 (en) * | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders |
| AU2005319367B2 (en) * | 2004-12-20 | 2012-05-24 | Collegium Pharmaceutical, Inc. | Pharmaceutical compositions for sleep disorders |
| JP5197361B2 (ja) * | 2005-06-06 | 2013-05-15 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ | 睡眠障害を処置するための組成物および方法 |
| WO2007026219A2 (en) * | 2005-08-31 | 2007-03-08 | Pfizer Products Inc. | Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions |
| WO2008103461A2 (en) * | 2007-02-21 | 2008-08-28 | Sepracor Inc. | Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof |
| WO2009023820A1 (en) * | 2007-08-16 | 2009-02-19 | Cypress Biosciences, Inc. | Improving the tolerability of a serotonin antagonist and a nsri, a snri or a rima by using them in combination |
-
2008
- 2008-04-08 CA CA2683697A patent/CA2683697C/en not_active Expired - Fee Related
- 2008-04-08 CN CN200880018706A patent/CN101686955A/zh active Pending
- 2008-04-08 NZ NZ580250A patent/NZ580250A/en not_active IP Right Cessation
- 2008-04-08 AR ARP080101456A patent/AR065989A1/es unknown
- 2008-04-08 EP EP12154458A patent/EP2455076A1/en not_active Withdrawn
- 2008-04-08 RU RU2009141168/15A patent/RU2009141168A/ru not_active Application Discontinuation
- 2008-04-08 KR KR1020097022364A patent/KR20100015923A/ko not_active Withdrawn
- 2008-04-08 BR BRPI0810159-0A2A patent/BRPI0810159A2/pt not_active Application Discontinuation
- 2008-04-08 MX MX2009010805A patent/MX2009010805A/es not_active Application Discontinuation
- 2008-04-08 JP JP2010503031A patent/JP2010523662A/ja active Pending
- 2008-04-08 EP EP08742623A patent/EP2142183A2/en not_active Withdrawn
- 2008-04-08 AU AU2008236624A patent/AU2008236624A1/en not_active Abandoned
- 2008-04-08 WO PCT/US2008/004508 patent/WO2008124128A2/en not_active Ceased
- 2008-04-09 US US12/100,382 patent/US20080293823A1/en not_active Abandoned
- 2008-04-09 TW TW097112888A patent/TW200901956A/zh unknown
-
2009
- 2009-10-11 IL IL201430A patent/IL201430A0/en unknown
-
2012
- 2012-05-25 US US13/481,597 patent/US20120238616A1/en not_active Abandoned
-
2015
- 2015-03-27 US US14/670,523 patent/US20150196531A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025120201A (ja) | 患者インターフェース | |
| US10271985B2 (en) | Valved nasal cannula | |
| JP5230202B2 (ja) | 呼吸デバイス及びそのキット | |
| JP5513519B2 (ja) | エアロゾル医薬輸送のための方法及びステップ構造を有するマウスピースを含む装置 | |
| CN103405843B (zh) | 一种随体位变化调节呼气正压的通气面罩 | |
| JP2009508854A (ja) | 睡眠時呼吸障害の予防及び治療方法及び手段 | |
| JP2010523662A5 (enExample) | ||
| DK1715859T3 (da) | Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden | |
| RU2009141168A (ru) | Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна | |
| Fahim et al. | Chronic opioid use: a risk factor for central sleep apnoea and successful therapy with adaptive pressure support servo-ventilation | |
| CN101291660A (zh) | 恢复正常呼吸节律的基于s-亚硝基硫醇的复方药品 | |
| WO2014028993A1 (pt) | Sistema dissuasivo do ronco e congéneres | |
| TWI872958B (zh) | 止鼾器 | |
| CN203425348U (zh) | 一种随体位变化调节呼气正压的通气面罩 | |
| Verse et al. | Sleep Disorders and the Nose: What Is the Evidence Base? | |
| Chakupurakal et al. | 1151 Lateral Head Position Improves Supine Predominant Obstructive Sleep Apnea | |
| Spencer et al. | 1152 The Case of the Auto-PAP that did not Work | |
| Verse | The Role of the Nose in Pharyngeal Obstructions | |
| Lenhardt et al. | Continuous positive airway pressure | |
| Lyons | Pediatric respiratory complication after general anesthesia with exposure to environmental tobacco smoke in the home: a case report. | |
| JP2012016600A (ja) | うつぶせ寝用枕 | |
| Patel et al. | Nasal High-Flow Oxygen Therapy for Sleep-Related Hypoventilation in Acute on Chronic Respiratory Failure | |
| Fahim | Sleep study and polysomnography data | |
| Amaro et al. | The Use Of Nasal Dilators As Placebo For Trials Using Continuous Positive Airway Pressure | |
| Neto et al. | Evaluation of the Use of an Intranasal Metallic Dilator in Patients with Obstructive Sleep Apnea Syndrome Using CPAP |